Quality of life and related dimensions in cancer patients treated with mistletoe extract (Iscador): A meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Büssing, Arndt ^a   Raak, Christa ^a   Ostermann, Thomas ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VISCUM ALBUM EXTRACT;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; HUMAN; KIDNEY CANCER; LUNG CANCER; MELANOMA; META ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; UTERINE CERVIX CANCER;

EID: 80052753545     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/219402     Document Type: Article

References (46)

1. Bausell R. B., Lee W. L., Berman B. M., Demographic and health-related correlates of visits to complementary and alternative medical providers Medical Care 2001 39 2 190 196 (Pubitemid 33603628)
2. Bssing A., Mistletoe. The Genus Viscum 2000 Amsterdam, The Netherlands Harwood Academic
3. Steiner R., Geisteswissenschaft und Medizin 1985 Dornach, Switzerland Rudolf Steiner
4. Steiner R., Steiner R., Besprechungen mit praktizierenden rzten Physiologisch-therapeutisches auf Grundlage der Geisteswissenschaft 1989 Dornach, Switzerland Rudolf Steiner 285 301
5. Bssing A., Beuth J., Moss R. W., Mistletoe extracts from an anthroposophical point of view Complementary Oncology. Adjunctive Methods in the Treatment of Cancer 2008 Stuttgart, Germany Thieme 197 2006
6. Kienle G. S., Berrino F., Bssing A., Portalupi E., Rosenzweig S., Kiene H., Mistletoe in cancera systematic review on controlled clinical trials European journal of medical research 2003 8 3 109 119
7. Bssing A., Bssing A., Overview on Viscum album L. products The Genus Viscum 2000 Amsterdam, The Netherlands Harwood Academic 209 221
8. Kiene H., Klinische Studien zur Misteltherapie karzinomatser Erkrankungen. Eine bersicht Therapeuticon 1989 3 347 353
9. Kienle G. S., Kiene H., Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts European Journal of Medical Research 2007 12 3 103 119 (Pubitemid 46564000)
10. Kienle G. S., Kiene H., Die Mistel in der Onkologie. Fakten und konzeptionelle Grundlagen 2003 Stuttagrt, Germany Schattauer
11. Ernst E., Schmidt K., Steuer-Vogt M. K., Mistletoe for cancer? A systematic review of randomised clinical trials International Journal of Cancer 2003 107 2 262 267 (Pubitemid 37152907)
12. Horneber M. A., Bueschel G., Huber R., Linde K., Rostock M., Mistletoe therapy in oncology Cochrane Database of Systematic Reviews 2008 2
13. Ostermann T., Raak C., Bssing A., Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review BMC Cancer 2009 9
14. Bssing A., Suzart K., Schweizer K., Differences in the apoptosis-inducing properties of Viscum album L. extracts Anti-Cancer Drugs 1997 8 supplement 1 S9 S14
15. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J. M., Gavaghan D. J., McQuay H. J., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1 1 12 (Pubitemid 26120810)
16. Stroup D. F., Berlin J. A., Morton S. C., Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group The Journal of the American Medical Association 2000 283 2008 2012 (Pubitemid 30214957)
17. Moher D., Cook D. J., Eastwood S., Olkin I., Rennie D., Stroup D. F., Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Lancet 1999 354 9193 1896 1900
18. Higgins J. P. T., Green S., Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.1 edn 2008 The Cochrane Collaboration
19. Wolf F. M., Meta-Analysis: Quantitative Methods for Research Synthesis 1986 Beverly Hills, Calif, USA Sage Publications
20. Sterne J. A. C., Egger M., Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis Journal of Clinical Epidemiology 2001 54 10 1046 1055 (Pubitemid 32888370)
21. Thompson S. G., Sharp S. J., Explaining heterogeneity in meta-analysis: a comparison of methods Statistics in Medicine 1999 18 20 2693 2708 (Pubitemid 29481404)
22. Higgins J. P. T., Thompson S. G., Quantifying heterogeneity in a meta-analysis Statistics in Medicine 2002 21 11 1539 1558 (Pubitemid 34746062)
23. Fleiss J. L., The statistical basis of meta-analysis Statistical Mmethods in Mmedical Research 1993 2 2 121 145
24. Borrelli E., Alberti G., Shaw J., Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy Minerva Medica 2005 92 105 107
25. Dold U., Edler L., Murer H. C., Sakellariou B., Trendelenburg F., Wagner G., Krebszusatztherapie beim fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom 1991 Stuttgart, Germany Georg Thieme
26. Grossarth-Maticek R., Kiene H., Baumgartner S. M., Ziegler R., Use of iscador, an extract of European mistletoe (Viscum Album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study Alternative Therapies in Health and Medicine 2001 7 3 57 78 (Pubitemid 32423640)
27. Grossarth-Maticek R., Kiene H., Baumgartner S. M., Ziegler R., Verlngerung der berlebenszeit von Krebspatienten unter Misteltherapie (Iscador) Schweizer Zeitschrift fr Ganzheitsmedizin 2001 13 217 225
28. Grossarth-Maticek R., Ziegler R., Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with mistletoe preparation (Iscador): a re-analysis European Journal of Medical Research 2006 11 11 485 495 (Pubitemid 44921394)
29. Grossarth-Maticek R., Ziegler R., Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) Forsch Komplement Med 2006 13 5 285 292 (Pubitemid 44641775)
30. Grossarth-Maticek R., Ziegler R., Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts Iscador Arzneimittelforschung 2007 57 665 678 (Pubitemid 350075413)
31. Grossarth-Maticek R., Ziegler R., Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador) Forsch Komplement Med 2007 14 3 140 147 (Pubitemid 47013381)
32. Grossarth-Maticek R., Ziegler R., Efficacy and safety of the long-term treatment of melanoma with a mistletoe preparation (Iscador)Wirksamkeit und unbedenklichkeit einer langzeitbehandlung von melanompatienten mit einem mistelprparat (Iscador) Schweizerische Zeitschrift fur GanzheitsMedizin 2007 19 6 325 332 (Pubitemid 350067941)
33. Grossarth-Maticek R., Ziegler R., Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador) European Journal of Medical Research 2008 13 3 107 120 (Pubitemid 351559881)
34. von Hagens C., Loewe-Mesch A., Kuehn J. J., Abel U., Gerhard I., Scheer R., Bauer R., Becker H., Fintelmann V., Kemper F. H., Schilcher H., Prospektive kontrollierte nicht randomisierte Machbarkeits-Studie zu einer postoperativen simultanen Mistel-/Chemotherapie bei Patientinnen mit MammakarzinomErgebnisse zu Rekrutier- und Randomisierbarkeit, Immunparametern, Lebensqualitt und Vertrglichkeit Fortschritte in der MisteltherapieAktueller Stand der Forschung und klinische Anwendung 2005 Essen, Germany Karl und Veronica Carstens-Stiftung 567 578
35. Kjaer M., Mistletoe (Iscador) therapy in stage 4 renal adenocarcinoma. A phase 2 study in patients with measurable lung metastases Acta Oncologica 1989 28 4 489 494 (Pubitemid 19238869)
36. Kjaer M., Misteltoe therapy of metastasizing kidney cancer. A phase 2 studyMisteltenbehandling af metastaserende nyrecancer. En fase 2 undersgelse Ugeskrift for Laeger 1988 150 39 2352 2354
37. Spitzer W. O., Dobson A. J., Hall J., Measuring the quality of life of cancer patients: a concise QL-index for use by physicians Journal of Chronic Diseases 1981 34 585 597 (Pubitemid 12237535)
38. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., De Haes J. C. J. M., Kaasa S., Klee M., Osoba D., Razavi D., Rofe P. B., Schraub S., Sneeuw K., Sullivan M., Takeda F., The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology Journal of the National Cancer Institute 1993 85 5 365 376 (Pubitemid 23073154)
39. Schag C. C., Heinrich R. L., Ganz P. A., Karnofsky performance status revisited: reliability, validity, and guidelines Journal of Clinical Oncology 1984 2 3 187 193 (Pubitemid 14138407)
40. Grossarth-Maticek R., Kiene H., Baumgartner S. M., Ziegler R., Synergieeffekte von Selbst-regulation und Misteltherapie (Iscador) auf die berlebenszeit bei Krebspatienten Schweizerische Zeitschrift fur GanzheitsMedizin 2004 16 2 81 89 (Pubitemid 38396893)
41. Bssing A., Girke M., Heckmann C., Schad F., Ostermann T., Krz M., Validation of the self regulation questionnaire as a measure of health in quality of life research European Journal of Medical Research 2009 14 5 223 227
42. Németh P., Hajt T., Fodor K., Perjési P., Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine Evidence-Based Complementary and Alternative Medicine 2011 2011 6
43. Bssing A., Trger W., Stumpf C., Schietzel M., Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life Anticancer Research 2008 28 1893 1897 (Pubitemid 351892902)
44. Diener H. C., Schorn C. F., Bingel U., Dodick D. W., The importance of placebo in headache research Cephalalgia 2008 28 10 1003 1011
45. Oeltjenbruns J., Schfer M., Clinical significance of the placebo effect Anaesthesist 2009 57 5 447 463
46. Kaptchuk T. J., The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Annals of Internal Medicine 2002 136 11 817 825 (Pubitemid 34568652)